Show simple item record

dc.contributor.authorSantiesteban Espejo, Antonio
dc.contributor.authorBernal-Florindo, Irene
dc.contributor.authorPérez-Requena, José
dc.contributor.authorAtienza Cuevas, Lidia 
dc.contributor.authorMorán Sánchez, Julia 
dc.contributor.authorFernandez-Valle, María del Carmen
dc.contributor.authorRomero‑García, Raquel
dc.contributor.authorGarcía-Rojo, Marcial
dc.contributor.otherAnatomía Patológica, Biología Celular, Histología, Historia de la Ciencia, Medicina Legal y Forense y Toxicologíaes_ES
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2022-06-15T09:40:56Z
dc.date.available2022-06-15T09:40:56Z
dc.date.issued2022-04
dc.identifier.issn2075-4418
dc.identifier.urihttp://hdl.handle.net/10498/26958
dc.description.abstractClassic Hodgkin lymphoma (cHL) constitutes a B cell-derived neoplasm defined by a scarce tumoral population, termed Hodgkin and Reed-Sternberg (HRS) cells, submerged into a histologically heterogeneous microenvironment. The paucity of HRS cells has historically hampered genetic studies, rendering the identification of the recurrent genetic lesions and molecular pathways deregulated in this lymphoma difficult. The advent of high-throughput sequencing methods such as next-generation sequencing (NGS) could sensibly optimize the identification of the mutational landscape of cHL. However, there is no current consensus either in the design of panels for targeted NGS or in its most relevant clinical applications. In this work, we systematically review the current state of NGS studies of cHL, stressing the need for standardization both in the candidate genes to be analyzed and the bioinformatic pipelines. As different institutions have developed and implemented their own customized NGS-based protocols, to compare and systematically review the major findings of this ongoing research area could be of added value for centers that routinely perform diagnostic, monitoring and genotyping strategies in cHL samples. The results of this systematic review should contribute to the interdepartmental harmonization and achievement of a consensus in the current clinical applications of NGS studies of cHL.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceDiagnostics, Vol. 12, Núm. 4es_ES
dc.subjectClassic Hodgkin lymphomaes_ES
dc.subjectstandardizationes_ES
dc.subjectnext-generation sequencinges_ES
dc.subjectliquid biopsyes_ES
dc.titleThe Need for Standardization in Next-Generation Sequencing Studies for Classic Hodgkin Lymphoma: A Systematic Reviewes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/diagnostics12040963


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional